Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence

BACKGROUND: Colorectal cancer (CRC) is the third most common cancer worldwide. Accurately identifying stage II CRC patients at risk for recurrence is an unmet clinical need. KCNQ1 was previously identified as a tumour suppressor gene and loss of expression was associated with poor survival in patien...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Br J Cancer
Main Authors: den Uil, Sjoerd H, Coupé, Veerle M H, Linnekamp, Janneke F, van den Broek, Evert, Goos, Jeroen A C M, Delis-van Diemen, Pien M, Belt, Eric J Th, van Grieken, Nicole C T, Scott, Patricia M, Vermeulen, Louis, Medema, Jan Paul, Bril, Herman, Stockmann, Hein B A C, Cormier, Robert T, Meijer, Gerrit A, Fijneman, Remond J A
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group 2016
נושאים:
Molecular Diagnostics
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5155368/
https://ncbi.nlm.nih.gov/pubmed/27855440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.376
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים